Leufkens HG - Search Results

1

Identification of exacerbations in obstructive lung disease through biomarkers.

Velthove KJ, Bracke M, Souverein PC, Schweizer RC, Ten Berg MJ, Leufkens HG, van Solinge WW. Velthove KJ, et al. Among authors: leufkens hg. Biomarkers. 2009 Nov;14(7):523-8. doi: 10.3109/13547500903150763. Biomarkers. 2009. PMID: 19863191

2

Asthma medications and disease exacerbations: an epidemiological study as a method for asthma surveillance.

Van Ganse E, van der Linden PD, Leufkens HG, Herings RM, Vincken W, Ernst P. Van Ganse E, et al. Among authors: leufkens hg. Eur Respir J. 1995 Nov;8(11):1856-60. doi: 10.1183/09031936.95.08111856. Eur Respir J. 1995. PMID: 8620952 Free article.

3

Antiallergic and antitussive medications: extent of use and relationship to asthma exacerbations.

Van Ganse E, Van der Linden P, Leufkens HG, Vincken W, Ernst P. Van Ganse E, et al. Among authors: leufkens hg. Therapie. 1996 Jul-Aug;51(4):373-7. Therapie. 1996. PMID: 8953811

4

Evaluating adverse cardiovascular effects of drug treatment for benign prostatic hyperplasia (BPH): methodological considerations.

Souverein PC, Herings RM, De la Rosette JJ, Man in 't Veld AJ, Farmer RD, Leufkens HG. Souverein PC, et al. Among authors: leufkens hg. J Clin Epidemiol. 2001 May;54(5):518-24. doi: 10.1016/s0895-4356(00)00327-9. J Clin Epidemiol. 2001. PMID: 11337216

5

The Dutch cohort of sildenafil users: baseline characteristics.

Souverein PC, Egberts AC, Sturkenboom MC, Meuleman EJ, Leufkens HG, Urquhart J. Souverein PC, et al. Among authors: leufkens hg. BJU Int. 2001 May;87(7):648-53. doi: 10.1046/j.1464-410x.2001.02174.x. BJU Int. 2001. PMID: 11350405

6

Incidence and determinants of sildenafil (dis)continuation: the Dutch cohort of sildenafil users.

Souverein PC, Egberts AC, Meuleman EJ, Urquhart J, Leufkens HG. Souverein PC, et al. Among authors: leufkens hg. Int J Impot Res. 2002 Aug;14(4):259-65. doi: 10.1038/sj.ijir.3900883. Int J Impot Res. 2002. PMID: 12152115

7

Study of the association between ischemic heart disease and use of alpha-blockers and finasteride indicated for the treatment of benign prostatic hyperplasia.

Souverein PC, Herings RM, Man in 't Veld AJ, de la Rosette JJ, Farmer RD, Leufkens HG. Souverein PC, et al. Among authors: leufkens hg. Eur Urol. 2002 Sep;42(3):254-61. doi: 10.1016/s0302-2838(02)00273-7. Eur Urol. 2002. PMID: 12234510

8

Drug treatment of benign prostatic hyperplasia and hospital admission for BPH-related surgery.

Souverein PC, Erkens JA, de la Rosette JJ, Leufkens HG, Herings RM. Souverein PC, et al. Among authors: leufkens hg. Eur Urol. 2003 May;43(5):528-34. doi: 10.1016/s0302-2838(03)00089-7. Eur Urol. 2003. PMID: 12705998

9

N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease.

Gerrits CM, Herings RM, Leufkens HG, Lammers JW. Gerrits CM, et al. Among authors: leufkens hg. Eur Respir J. 2003 May;21(5):795-8. doi: 10.1183/09031936.03.00063402. Eur Respir J. 2003. PMID: 12765423 Free article.

10

Use of alpha-blockers and the risk of hip/femur fractures.

Souverein PC, Van Staa TP, Egberts AC, De la Rosette JJ, Cooper C, Leufkens HG. Souverein PC, et al. Among authors: leufkens hg. J Intern Med. 2003 Dec;254(6):548-54. doi: 10.1111/j.1365-2796.2003.01227.x. J Intern Med. 2003. PMID: 14641795 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

541 results

Search Page

Filters